Close Menu

NEW YORK – lllumina reported after the close of the market on Thursday that its fourth quarter 2020 revenues were flat, echoing its forecast at the virtual JP Morgan Healthcare conference in January.

For the three months ended Jan. 3, 2021, Illumina reported total revenues of $953 million, the same as a year ago and above analysts' average estimate of $903.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.